Back
Ocular Therapeutix Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Buy
69
OCUL
Ocular Therapeutix
Last Price:
6.18
Seasonality Move:
-2.15%
Buy
65
REGN
Regeneron Pharmaceuticals
Last Price:
982.60
Seasonality Move:
8.1%
Buy
69
Ocular Therapeutix (OCUL)
is a Buy
Is Ocular Therapeutix a Buy, Sell or Hold?
- The current Ocular Therapeutix [OCUL] share price is $6.17. The Score for OCUL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- OCUL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $982.29. The Score for REGN is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- REGN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
OCUL Stock Price Chart
What is Ocular Therapeutix's stock price today?
-
The Ocular Therapeutix share price today is $6.17
The current trend is relatively stagnant and OCUL is experiencing slight buying pressure.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $982.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
OCUL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 49.06 | Sell |
Chaikin Money Flow: | 169488 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.84 - 6.68) | Buy |
Bollinger Bands (100): | (4.58 - 8.98) | Sell |
REGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 14.5 | Buy |
Relative Strength Index (14 RSI): | 64.04 | Buy |
Chaikin Money Flow: | 364335 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (893.96 - 967.54) | Buy |
Bollinger Bands (100): | (910.83 - 972.27) | Buy |
OCUL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.96 | Buy |
20-day SMA: | 5.48 | Buy |
50-day SMA: | 7.4 | Sell |
200-day SMA: | 5.01 | Buy |
8-day EMA: | 6.01 | Buy |
20-day EMA: | 6.05 | Buy |
50-day EMA: | 6.62 | Sell |
200-day EMA: | 5.79 | Buy |
REGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 973.46 | Buy |
20-day SMA: | 939.22 | Buy |
50-day SMA: | 942.8 | Buy |
200-day SMA: | 880.68 | Buy |
8-day EMA: | 970.66 | Buy |
20-day EMA: | 952.53 | Buy |
50-day EMA: | 942.21 | Buy |
200-day EMA: | 886.86 | Buy |
Ocular Therapeutix Earnings Growth & OCUL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.19 per share, and an increase next year of $0.26 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.30 per share, an increase this year of $1.59 per share, and an increase next year of $3.24 per share.
Ocular Therapeutix Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regeneron Pharmaceuticals Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |